Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry

Eur Heart J

18 July Jul 2024 3 months ago
  • Tondo C.

Prior reports have demonstrated a favourable safety and efficacy profile of the Micra leadless pacemaker over mid-term follow-up; however, long-term outcomes in real-world clinical practice remain unknown. Updated performance of the Micra VR leadless pacemaker through five years from the worldwide post-approval registry (PAR) was assessed.

Reference: Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry. El-Chami MF, Garweg C, Clementy N, Al-Samadi F, Iacopino S, Martinez-Sande JL, Roberts PR, Tondo C, Johansen JB, Vinolas-Prat X, Cha YM, Grubman E, Bordachar P, Stromberg K, Fagan DH, Piccini JP. Eur Heart J. 2024 Mar 1:ehae101.

Go to PubMed